Navigating climate-focused AI funding offers a unique milestone for turning research concepts into transformative tools. CEO Aaron Schacht describes how BiomEdit’s Bezos-funded “digital twin” work aims to model genetics, feed and microbiome to predict performance and methane reduction, creating a platform that could serve both producers and future commercial partners.

Harnessing the power of real-world evidence is critical to scaling precision medicine. Christina Lopes, Co-Founder & CEO of FidoCure, shares how the company built a canine cancer dataset and leveraged AI to transform data points into targeted therapies, driving adoption beyond oncology specialists and enabling validated and scalable solutions.